Menu
MapConnectionsTopicsBulgariaThe Night (K-TRIO)Marie Skłodowska-CurieFor studentsFor teachersMethodologySurprise me
HEIndividual fellowship2022–2025

IMMUNOBAT · Elucidating the crosstalk between the immune system and brown adipose tissue in humans

Horizon Europe — Marie Skłodowska-Curie Actions

Duration
2022-05-01 → 2025-06-30
EU contribution
€211,948
Participants
1
Scheme
HORIZON-TMA-MSCA-PF-EF

Lines connect the coordinator with its partners.

Results in brief

Elucidating the crosstalk between the immune system and brown adipose tissue in humans

Brown fat, also called brown adipose tissue (BAT), is a special type of fat in our bodies that relates to better cardiometabolic health. However, in people with obesity, BAT seems to be dysfunctional. Therefore, it is important to understand what mechanisms regulate human BAT (hBAT) and to find new ways and strategies to improve it. Research in mice has shown that immune cells - the cells that normally protect us from infections - also play a role in controlling how BAT works. For example, certain immune cells can help activate BAT when exposed to cold temperatures. But in humans, we still do not fully know which immune cells are involved, or whether they could be targeted to make BAT more active and healthier. The IMMUNOBAT project set out to answer three main questions: 1. Which immune cells are found inside hBAT? 2. Is there inflammation in the hBAT of people with obesity, and does this explain why it works less efficiently? 3. Can cold exposure (for three months) improve BAT activity in people with obesity, and is this linked to changes in hBAT immune cells? Through this project, we hoped to understand how immune cells and BAT interact in humans, why BAT is less active in obesity, and how cold exposure could be used as a strategy to improve cardiometabolic health.

Data: CORDIS, © European Union

Project objective

Brown adipose tissue (BAT) is a promising therapeutic target to improve cardiometabolic health. However, BAT metabolism is dysfunctional in obesity. Hence, it is highly relevant to ascertain which mechanisms modulate BAT function and how it can be improved in this context.Mice studies indicate that the immune cells-brown adipocytes molecular interactions within BAT modulate its function. Indeed, mice knockout for the transcript Mecp2 in BAT macrophages show impaired BAT function and develop obesity. Further, cold acclimation activates specific subsets of infiltrated immune cells which improves BAT function. Altogether points to infiltrated immune cells as key players regulating BAT- but their identity and role, and if they can be targeted to activate BAT in humans, is unknown.The main questions we aim to tackle are: i) Which are the immune cell populations within human BAT? ii) Does local inflammation exist in BAT of obese subjects? Is it related to their disrupted BAT oxidative and metabolic capacity? iii) Is the BAT oxidative and metabolic capacity improvement, after a 3-month cold acclimation, driven by changes in BAT immune cell profile? To answer these questions, IMMUNOBAT will characterize the immune cell profile of BAT in lean and obese subjects, using novel single-cell omics in samples obtained by neck surgery. BAT oxidative and metabolic capacity will be assessed in vivo by state-of-art methods, combining the use of 15O-O2 and 15O-H2O - PET measures with in vitro mitochondrial respiration assays of brown adipocytes. These measures will be repeated in obese subjects after a 3-month cold acclimation (the most powerful stimulus to activate BAT).IMMUNOBAT will provide new mechanistic insights into obesity pathogenesis, at the same time that it expects to find new tools to improve cardiometabolic health by activating BAT. Further, it will promote the fellow´s training in adipose biology and immunology, and his growth as an independent and mature researcher

Original text from CORDIS.

Participants

  • TURUN YLIOPISTO · TurkuCoordinatorFinland

Links

Data: CORDIS, © European Union